Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TP53 mutations in AML predict adverse outcome in patients undergoing allogeneic hematopoietic stem cell transplant
    Meeting Abstract

    Getta, B. M.; Ghosh, A.; Coombs, C. C.; Devlin, S.; Arcila, M.; Mohanty, A.; Levine, R. L.; Tallman, M. S.; Jakubowski, A. A.; Giralt, S. A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation is underutilized in patients with myelodysplastic syndromes
    Meeting Abstract

    Getta, B.; Kishtagari, A.; Hilden, P.; Devlin, S.; Maloy, M. A.; Gonzales, P. K.; Shaffer, B. C.; Ponce, D. M.; Gyurkocza, B.; Barker, J. N.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Novel associations between mutations, prognostic and clinical parameters in untreated progressive CLL: Data from E1912, a randomized phase III study of the ECOG-ACRIN Cancer Research Group
    Meeting Abstract

    Braggio, E.; Wang, V. X.; Garcia, S.; Bruins, L. A.; Lesnick, C.; Barrientos, J. C.; O'Brien, S. M.; Tallman, M. S.; Fonseca, R.; Kay, N. E.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A phase I/II open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in subjects with relapsed, refractory hematologic malignancies
    Meeting Abstract

    Borthakur, G.; Dawson, M. A.; Stein, E. M.; Karadimitris, A.; Huntly, B. J. P.; Dickinson, M. J.; Chaidos, A.; Horner, T.; Brennan, J.; Baron, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The selective anti leukemic effect of BL-8040, a peptidic CXCR4 antagonist, is mediated by induction of leukemic blast mobilization, differentiation and apoptosis: Results of correlative studies from a Ph2a trial in acute myeloid leukemia
    Meeting Abstract

    Borthakur, G.; Tallman, M. S.; Ofran, Y.; Foran, J. M.; Uy, G. L.; DiPersio, J. F.; Nagler, A.; Rowe, J. M.; Showel, M. M.; Altman, J.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A distributed international patient data registry for hairy cell leukemia
    Meeting Abstract

    Andritsos, L. A.; Grever, M. R.; Anghelina, M.; Dearden, C. E.; Else, M.; Blachly, J. S.; Lele, O.; Ravandi, F.; Zent, C. S.; Johnston, J. B.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL
    Journal Article

    Ravandi, F.; Othus, M.; O'Brien, S. M.; Forman, S. J.; Ha, C. S.; Wong, J. Y. C.; Tallman, M. S.; Paietta, E.; Racevskis, J.; Uy, G. L.; more...
    Blood Advances (2016)

    Fulltext@MSK | Save
  • Imatinib discontinuation and Tki switching patterns in the retrospective and prospective cohorts in simplicity, a study of chronic-phase chronic myeloid leukemia (Cp-Cml) patients (Pts) in routine clinical practice
    Meeting Abstract

    Zyczynski, T.; Khoury, J.; Goldberg, S.; Mauro, M.; Michallet, M.; Paquette, R.; Foreman, A.; Subar, M.; Turner, M.; Daumont, M. M.; more...
    Value in Health (2016)

    Fulltext@MSK | Save
  • Evolving therapies in acute myeloid leukemia: Progress at last?
    Journal Article

    DeAngelo, D. J.; Stein, E. M.; Ravandi, F.
    American Society of Clinical Oncology Educational Book (2016)

    Fulltext@MSK | Save
  • Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis
    Journal Article

    Das, R.; Guan, P.; Sprague, L.; Verbist, K.; Tedrick, P.; An, Q. A.; Cheng, C.; Kurachi, M.; Levine, R.; Wherry, E. J.; more...
    Blood (2016)

    Fulltext@MSK | Save